AIS

16 registered clinical trials studyying AIS — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Eff NCT07520565	Biocells (Beijing) Biotech Co.,Ltd	Phase 3
Not Yet Recruiting	A Randomized Clinical Trial on Urgent Angioplasty for IntraCranial Atherosclerotic Stenosis-related Large-Vess NCT06702657	Changhai Hospital	N/A
Active Not Recruiting	Acute Training Effect Assessment in Adolescent Idiopathic Scoliosis NCT07194564	The University of Hong Kong	N/A
Completed	Cervical Alignment Changes After Correction of Thoracic Adolescent Idiopathic Scoliosis With Thoracic Hypokyph NCT06251505	Istituto Ortopedico Rizzoli	—
Completed	Search for a Recanalization of the Sylvian Artery Electro-Physiological Biomarker NCT05473975	Fondation Ophtalmologique Adolphe de Rothschild	—
Terminated	A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Ch NCT05584332	Shanghai Bovax Biotechnology Co., Ltd.	Phase 3
Recruiting	Screening and Intervention for AIS in Haikou, Hainan Province, China NCT05466383	Chaoyin Jiang	N/A
Recruiting	Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Year NCT04895020	Shanghai Bovax Biotechnology Co., Ltd.	Phase 3
Unknown	Investigating the Potential Psychological Impact of Early Screening and Long-term Monitoring for Adolescent Id NCT05152329	The University of Hong Kong	—
Completed	A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischem NCT05496361	Suzhou Zenith Vascular Scitech Co., Ltd.	N/A
Completed	Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT05372016	Shanghai Bovax Biotechnology Co., Ltd.	Phase 3
Completed	Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Fem NCT04425291	Shanghai Bovax Biotechnology Co., Ltd.	Phase 3
Recruiting	Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Female NCT04422366	Shanghai Bovax Biotechnology Co., Ltd.	Phase 3
Completed	Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT03676101	Shanghai Bovax Biotechnology Co., Ltd.	Phase 1
Completed	NBP in Adult Patients With Acute Ischemic Stroke (AIS) NCT02905565	CSPC-NBP Pharmaceutical Co., Ltd.	Phase 2
Unknown	Evaluation of the AIIS Using Hip Ultrasound(AIISUS) NCT03105063	Tel-Aviv Sourasky Medical Center	N/A